Table 2.
Treatments (mg/kg) | Bone marrow erythrocytes*
|
Peripheral blood erythrocytes**
|
|
---|---|---|---|
MNPCE Mean ± SD | PCE/NCE | MNPCE Mean ± SD | |
Negative control | 3.83 ± 1.78 | 1.47 ± 0.44 | 1.50 ± 1.04 |
Solvent control | 2.0 ± 1.41 | 1.42 ± 0.27 | 1.50 ± 1.22 |
Positive control | 31.16 ± 7.90a, b | 1.31 ± 0.14 | 14.16 ± 5.11a, b |
| |||
Oil-resin | |||
500 | 2.83 ± 1.72 | 1.26 ± 0.17 | 1.66 ± 1.50 |
1000 | 2.83 ± 0.75 | 1.74 ± 0.68 | 1.16 ± 0.75 |
2000 | 2.66 ± 0.81 | 1.48 ± 0.19 | 1.33 ± 1.03 |
| |||
Volatile fraction | |||
500 | 2.16 ± 1.16 | 1.51 ± 0.21 | 1.33 ± 1.03 |
1000 | 2.66 ± 0.91 | 1.41 ± 0,21 | 0.83 ± 0.70 |
2000 | 4.16 ± 1.72 | 1.27 ± 0.33 | 1.33 ± 1.03 |
| |||
Resin fraction | |||
500 | 4.66 ± 1.03 | 1.32 ± 0.27 | 2.16 ± 1.16 |
1000 | 2.50 ± 1.51 | 1.28 ± 0.12 | 1.83 ± 1.04 |
2,000 PCE were analyzed per animal, with six animals per group.
1,000 PCE were analyzed per animal.
p < 0.05 compared to negative control.
p < 0.05 compared to solvent control. One way-ANOVA and post-hoc Tukey test.